
Angiogenesi
Sottocategorie di "Angiogenesi"
- BTK(165 prodotti)
- Bcr-Abl(117 prodotti)
- EGFR(562 prodotti)
- FAK(72 prodotti)
- FLT(89 prodotti)
- Recettore del fattore di crescita dei fibroblasti (FGFR)(177 prodotti)
- JAK(245 prodotti)
- PDGFR(127 prodotti)
- RAAS(86 prodotti)
- Src(82 prodotti)
- Syk(37 prodotti)
- Trombina(51 prodotti)
- VDA(2 prodotti)
- VEGFR(239 prodotti)
Trovati 2243 prodotti di "Angiogenesi"
(Rac)-SAR131675
CAS:(Rac)-SAR131675 is an effective and specific VEGFR-3 inhibitor, which inhibited VEGFR-3 tyrosine kinase activity and VEGFR-3 autophosphorylation in HEK cells.Formula:C18H22N4O4Purezza:98.73% - 99.1%Colore e forma:SolidPeso molecolare:358.39(5E)-5-(4-Hydroxybenzylidene)-1,3-thiazolidine-2,4-dione
CAS:Prodotto controllatoApplications 5-[(4-Hydroxyphenyl)methylene]-2,4-thiazolidinedione is a 5-Benzylidene-2,4-thiazolidenedione derivative designed as inhibitors of angiogenesis targeting VEGFR-2. Also, it is an intermediate used in the synthesis of MSDC 0602 (M755420), which is an analogue of thiazolidinediones, exhibits low affinity for binding and activation of peroxisome proliferator-activated receptor γ (PPARγ). Thiazolidinediones are effective insulin-sensitizing drugs for treating various metabolic and inflammatory diseases.
References Bhanushali, U., et al.: Bioorg. Chem., 67, 139-147 (2016); Chen, Z., et al.: J. Biol. Chem. 287, 23537 (2012); Fukunaga, T., et al.: J. Bone Miner. Res., 30, 508 (2015)Formula:C10H7NO3SColore e forma:NeatPeso molecolare:221.23Methyl 6-[[[(2-Chloroethyl)amino]carbonyl]amino]-6-deoxy-α-D-glucopyranoside
CAS:Prodotto controllatoFormula:C10H19ClN2O6Colore e forma:NeatPeso molecolare:298.72Dilpacimab
CAS:Dilpacimab (ABT165) is a dual-variable antibody that targets DLL4 and VEGF pathways, showing potential in cancer research by blocking angiogenesis and Notch.Purezza:95% - 97.7% (SDS-PAGE); 95.6% (SEC-HPLC)Colore e forma:LiquidAnti-Mouse VEGFR-2 Antibody (DC101)
Anti-Mouse VEGFR-2 Antibody (DC101) is a rat-derived monoclonal antibody against mouse VEGFR2/KDR/Flk-1, serving as a mouse analogue of ramucirumab.Purezza:99%Colore e forma:LiquidPeso molecolare:150 kDaSolrikitug
CAS:Solrikitug,Anti-CRLF2 humanized IgG1κ monoclonal antibody.Purezza:95%Colore e forma:LiquidPeso molecolare:~150 kDaIzalontamab
CAS:Izalontamab (SI-B001) is a bispecific EGFR/HER3 monoclonal antibody that binds to both EGFR×EGFR homodimers and EGFR×HER3 heterodimers.Purezza:95%+ - 95.3% (SDS-PAGE); 99.2% (SEC-HPLC)Colore e forma:LiquidPeso molecolare:197.21 kDaImgatuzumab
CAS:Imgatuzumab (RG 7160) is a humanized anti-EGFR monoclonal antibody and immunomodulator for cancer research.
Colore e forma:LiquidPeso molecolare:145.0 (kDa)Fidasimtamab
CAS:Fidasimtamab, a recombinant human IgG1 bispecific antibody, targets both HER2 and PD-1, bridging T cells and tumor cells to modulate immune responses.Purezza:95% - 98.0% (SDS-PAGE); 98.3% (SEC-HPLC)Colore e forma:LiquidTarcocimab
CAS:Tarcocimab (OG1953) is a humanized IgG1 monoclonal antibody targeting VEGFA, researched for RVO and wet AMD.Colore e forma:LiquidZanidatamab
CAS:Zanidatamab (ZW25) is a bispecific, humanized monoclonal antibody that targets two distinct epitopes (ECD2 and ECD4) of the HER2 receptor, exhibiting anti-tumorColore e forma:LiquidSerclutamab
CAS:Serclutamab, a humanized chimeric monoclonal antibody of the IgG1-κ isotype, selectively targets the epidermal growth factor receptor (EGFR).
Purezza:98%Colore e forma:LiquidDepatuxizumab
CAS:Depatuxizumab is a humanised monoclonal antibody targeting EGFR with blood-brain barrier (BBB) permeability, inhibit tumor growth,GBM,SCCHN.Purezza:95%Colore e forma:LiquidEGFR T790M/L858R-IN-8
CAS:EGFRT790M/L858R-IN-8 (compound 9) is a potent inhibitor of EGFR, specifically targeting the EGFRT790M/L858R mutations with an IC50 of 56.8 μM. This compound does not show significant antiproliferative effects on cancer cell lines A549, A431, and NHI-H1975.Formula:C16H11BrN2O3Colore e forma:SolidPeso molecolare:359.17Vanucizumab
CAS:Vanucizumab is a bispecific humanised monoclonal antibody that simultaneously inhibits the receptor interactions of VEGF-A and Angiopoietin-2 (Ang-2)
Purezza:95%Colore e forma:LiquidIvonescimab
CAS:Ivonescimab (AK112) is a PD-1/VEGF bispecific antibody with cancer immunotherapy and anti-angiogenic effects, NSCLC).Purezza:95% - >95.0% (SDS-PAGE); 98.99% (SEC-HPLC)Colore e forma:LiquidPeso molecolare:201.12 kDaIbrutinib-d5
CAS:Ibrutinib D5 is a deuterium-labeled Ibrutinib. Ibrutinib is an irreversible Btk inhibitor.Formula:C25H24N6O2Purezza:98%Colore e forma:SolidPeso molecolare:445.53Dasatinib-d8
CAS:Dasatinib D8 is deuterium-labeled dasatinib. Dasatinib is a dual Bcr-Abl and Src family tyrosine kinase inhibitor.Formula:C22H26ClN7O2SPurezza:98%Colore e forma:SolidPeso molecolare:496.06Apatinib-d8
CAS:Apatinib-d8 is a deuterated compound of Apatinib. Apatinib has a CAS number of 811803-05-1. Apatinib is an orally bioavailable and specific VEGFR2 inhibitor (IC50: 1 nM). In addition, this agent mildly inhibits c-Kit and c-SRC tyrosine kinases.Formula:C24H15D8N5OColore e forma:SolidPeso molecolare:405.52Dovitinib Dilactic Acid
CAS:Dovitinib dilactic acid: multitarget RTK inhibitor for FLT3/c-Kit (IC50=1-2 nM), FGFR1/3, VEGFR1-4 (IC50=8-13 nM), less effective on InsR, EGFR. Phase 4.Formula:C21H21FN6O·2C3H6O3Purezza:98%Colore e forma:SolidPeso molecolare:572.59


